Novartis India Limited (BOM:500672)
India · Delayed Price · Currency is INR 1,589.20
+2.50 (0.16%)
At close: Aug 17, 2026
Novartis India Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 39,177 | 23,970 | 19,384 | 25,396 | 13,958 | 14,579 | |
Market Cap Growth | 66.89% | 23.66% | -23.67% | 81.95% | -4.26% | 6.97% |
Enterprise Value | 32,532 | 17,837 | 13,471 | 20,578 | 8,526 | 10,036 |
Last Close Price | 1586.70 | 970.80 | 766.56 | 982.89 | 511.81 | 526.52 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 40.07 | 25.72 | 19.21 | 29.81 | 13.50 | - |
PS Ratio | 10.57 | 6.77 | 5.44 | 7.58 | 3.69 | 3.65 |
PB Ratio | 4.79 | 2.93 | 2.47 | 3.41 | 1.80 | 2.11 |
P/TBV Ratio | 4.79 | 2.93 | 2.47 | 3.41 | 1.80 | 2.11 |
P/FCF Ratio | 84.45 | 51.67 | 25.99 | 22.40 | 31.37 | 38.19 |
P/OCF Ratio | 83.84 | 51.29 | 25.99 | 22.40 | 31.16 | 37.70 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 8.78 | 5.03 | 3.78 | 6.14 | 2.25 | 2.51 |
EV/EBITDA Ratio | 31.82 | 18.96 | 14.97 | 32.61 | 13.79 | 39.13 |
EV/EBIT Ratio | 32.55 | 19.36 | 15.05 | 32.70 | 14.19 | 42.22 |
EV/FCF Ratio | 70.13 | 38.45 | 18.07 | 18.15 | 19.16 | 26.29 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.03 | 0.04 |
Debt / EBITDA Ratio | 0.03 | 0.03 | 0.06 | 0.11 | 0.33 | 0.72 |
Debt / FCF Ratio | - | 0.07 | 0.07 | 0.06 | 0.48 | 0.63 |
Net Debt / Equity Ratio | -0.81 | -0.81 | -0.80 | -0.78 | -0.69 | -0.71 |
Net Debt / EBITDA Ratio | -6.50 | -7.06 | -7.02 | -9.16 | -8.62 | -19.19 |
Net Debt / FCF Ratio | - | -14.32 | -8.47 | -5.10 | -11.98 | -12.90 |
Asset Turnover | - | 0.37 | 0.38 | 0.35 | 0.39 | 0.41 |
Inventory Turnover | - | 4.20 | 4.72 | 4.02 | 3.61 | 3.39 |
Quick Ratio | - | 4.86 | 4.83 | 4.05 | 3.78 | 2.65 |
Current Ratio | - | 5.30 | 5.25 | 4.45 | 4.25 | 3.28 |
Return on Equity (ROE) | - | 11.63% | 13.19% | 11.21% | 14.09% | -0.53% |
Return on Assets (ROA) | - | 5.98% | 5.97% | 4.12% | 3.87% | 1.52% |
Return on Invested Capital (ROIC) | 46.98% | 43.24% | 43.32% | 21.31% | 24.34% | 9.99% |
Return on Capital Employed (ROCE) | - | 11.10% | 11.10% | 8.20% | 7.30% | 3.20% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 2.50% | 3.89% | 5.21% | 3.36% | 7.41% | -0.26% |
FCF Yield | 1.18% | 1.93% | 3.85% | 4.46% | 3.19% | 2.62% |
Dividend Yield | 1.58% | - | 3.26% | 2.54% | 1.95% | 1.90% |
Payout Ratio | - | 66.25% | 61.18% | 137.67% | 23.89% | - |
Buyback Yield / Dilution | -0.02% | 0.00% | - | - | - | - |
Total Shareholder Return | 1.56% | 0.00% | 3.26% | 2.54% | 1.95% | 1.90% |